Ovarian cancer

Open Access
Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II
INGIRIDUR SKIRNISDOTTIR, HELENA AKERUD, TOMAS SEIDAL and INGER SUNDSTROM-POROMAA

Cancer Genomics & Proteomics November 2019, 16 (6) 443-450; DOI: https://doi.org/10.21873/cgp.20148
Open Access
Regulation of REG4 Expression and Prediction of 5-Fluorouracil Sensitivity by CDX2 in Ovarian Mucinous Carcinoma
IEMASA KOH, SUGURU NOSAKA, MASAKI SEKINE, JUN SUGIMOTO, EIJI HIRATA and YOSHIKI KUDO

Cancer Genomics & Proteomics November 2019, 16 (6) 481-490; DOI: https://doi.org/10.21873/cgp.20151
Open Access
Leptin Receptor Antagonists' Action on HDAC Expression Eliminating the Negative Effects of Leptin in Ovarian Cancer
ELŻBIETA FIEDOR, KAROLINA ZAJDA and EWA L. GREGORASZCZUK

Cancer Genomics & Proteomics July 2018, 15 (4) 329-336; DOI: https://doi.org/10.21873/cgp.20091
Open Access
Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins
ISA N. CRUZ, HELEN M. COLEY, HOLGER B. KRAMER, THUMULURU KAVITAH MADHURI, NUR A.M. SAFUWAN, ANA RITA ANGELINO and MIN YANG

Cancer Genomics & Proteomics January 2017, 14 (1) 35-51;
Open Access
A Low-density Antigen Array for Detection of Disease-associated Autoantibodies in Human Plasma
RICHARD I. SOMIARI, REBECCA SUTPHEN, KUTRALANATHAN RENGANATHAN, STEPHEN RUSSELL, ELZBIETA PASTWA and STELLA A. SOMIARI

Cancer Genomics & Proteomics January 2016, 13 (1) 13-19;
You have access
Association of p21, p21 p27 and p21 p53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer
INGIRIDUR SKIRNISDOTTIR and TOMAS SEIDAL

Cancer Genomics & Proteomics January 2013, 10 (1) 27-34;

Main menu

User menu

Search

Ovarian cancer